Search results (9)
« Back to NewsIn memoriam: Professor Tim Crow OBE
26 November 2024
Delusions Psychosis Schizophrenia
The influential and pioneering psychiatric researcher Professor Timothy Crow OBE, who was a member of the Department of Psychiatry at Oxford, has died at the age of 86.
Artificial intelligence (AI) language tools could be used to help detect mental health conditions
10 October 2023
Scientists are using AI to detect language differences in people with mental health difficulties that could eventually be used to help diagnose and monitor psychiatric conditions.
Prioritising the children of parents with severe mental illness
24 July 2023
Bipolar Disorder Child and Adolescent Psychiatry Child and adolescent Schizophrenia
The needs of children whose parents have severe mental illness should be prioritised, according to a new paper written by a consortium of international experts.
New study reveals clinical instability can predict psychiatric hospitalisation
28 March 2023
Bipolar Disorder Depression Mental Health Schizophrenia
For patients with psychiatric conditions, data shows that both illness severity and instability are key factors in predicting their future risk of hospitalisation.
Major trials to test effectiveness of cannabidiol on psychosis
16 February 2023
Psychosis Randomised controlled trial Schizophrenia
Global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.
Review Highlights Risk Factors Associated with Violence in Schizophrenia
20 January 2022
Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).
Investigating New Treatment for Schizophrenia
21 January 2021
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
First Female Professor of Psychiatry in the Department
20 August 2019
Awards Mental Health Psychosis Schizophrenia
Professor Belinda Lennox has been given the title of Professor of Psychiatry in the 2019 Recognition of Distinction Exercise at the University of Oxford.
Virtual Reality Could Transform Psychological Therapy in the NHS
27 June 2019
Anxiety Early intervention Mental Health Psychological therapy Schizophrenia Virtual reality
A new clinical trial is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical trial of virtual reality for a mental health disorder. Automated delivery of therapy using VR has potential to transform NHS provision of psychological therapy.